Caused by heart and/or blood-vascular system disorders, cardiovascular (CDV) diseases kill almost 17 million people annually. The cardiovascular market can be divided the following key segments: cardiac surgery, cardiac rhythm management (abbreviated as CRM) and interventional cardiology. There is a wide range of products on offer in the market: defibrillators, introducers, catheters, pacemakers, among others.
The growth of the cardiovascular market is driven by the aging population, rising incidence of chronic CDV, innovations and technology advancements in the cardiovascular industry and constantly improving treatment capabilities. The USA is the largest cardiovascular market, with AstraZeneca , Merck & Co. , Bristol-Myers Squibb (BMS), Novartis , Sanofi-Aventis and Pfizerbeing amid the most prominent market participants.
Comprehensive assessment of the cardiovascular market at various geographical scales and over different time spans is provided in the research reports found under this catalogue. Data demand and supply trends, research and development activities, and leading market players are at hand in the reports. Moreover, future prospects for the market are disclosed in the research reports.
Publications found:
107
Sort by:
Global Heart Valve Market Report: 2011 Edition
US$ 800.00
... obesity are the major factors which are driving the global heart valve market growth. Moreover, rising urban population which leads ... report provides an analysis of the global heart valve market. It also discusses the major trends, growth drivers and potential markets for heart valve market. The report ...
February 2012
35 pages
Analysis of Congenital Heart Diseases Market
US$ 800.00
... babies are born with VSD in the United States. Most congenital heart diseases are diagnosed in babies (aged under a year), 30% in children (aged 1-15 ... current report analyzes the market size and segmentation of the congenital heart diseases market. The various drivers, opportunities and the challenges faced ...
June 2010
36 pages
Worldwide Heart Valve Market Report: 2010 Edition
US$ 800.00
... overall heart valve market and provide higher risk patients with a less invasive approach. The penetration of worldwide risk/ ... valve segment. The report provides an analysis of the global heart valve market. It also discusses major trends, growth drivers and potential markets for heart valve market. The report ...
June 2010
33 pages
Interventional Cardiology: Market Research Report
US$ 4,450.00
This report analyzes the worldwide markets for Interventional Cardiology in US$ Million. The market for Interventional Cardiology Devices is analyzed by the following product segments: Coronary Stents, Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, Vascular Sealings/ Vascular Closure ...
June 2010
492 pages
Growth Opportunities for LVAD in Heart Failure Market
US$ 750.00
... indication established by the FDA, would also open new growth avenues for LVADs. The report provides an overview of the heart failure and ... the associated end stage heart failure cost and LVAD reimbursement. The growth drivers and challenges are also discussed. The key ...
February 2010
36 pages
Worldwide Heart Valve Market: Focus on Tissue Valves
US$ 800.00
... worldwide annually. In the US alone, around five million people suffer from heart problems. In heart valve market, mechanical valves are more durable than tissue heart valves ... of the heart valve market. It analyzes the worldwide and US market. Apart from providing a competitive landscape of the market, the ...
May 2008
24 pages
